xyrem
ucb pharma ltd - natrio oksibatas - cataplexy; narcolepsy - kiti nervų sistemos vaistai - suaugusiems pacientams narkolepsija su katapleksija gydoma.
femoston conti
viatris healthcare limited - estradiolis/didrogesteronas - plėvele dengtos tabletės - 0,5 mg/2,5 mg - dydrogesterone and estrogen
ipraalox
opella healthcare france sas - pantoprazolas - skrandyje neirios tabletės - 20 mg - pantoprazole
metother
accord healthcare b.v. - metotreksatas - injekcinis tirpalas užpildytame švirkšte - 50 mg/ml - methotrexate
brumare
viatris healthcare limited - ibuprofenas - šnypščiosios granulės - 400 mg - ibuprofen
calcigran forte orange
orifarm healthcare a/s - kalcis/kolekalciferolis - kramtomosios tabletės - 1000 mg/800 tv; 500 mg/400 tv; 500 mg/800 tv - calcium, combinations with vitamin d and
linezolid accord
accord healthcare b.v. - linezolidas - infuzinis tirpalas - 2 mg/ml - linezolid
theraflu sn
glaxosmithkline consumer healthcare (uk) trading limited - paracetamolis/pseudoefedrinas - sirupas - 500 mg/30 mg/30 ml - other cold preparations ;paracetamol, combinations excl. psycholeptics
dutasteride/tamsulosin accord
accord healthcare b.v. - dutasteridas/tamsulozino hidrochloridas - kietosios kapsulės - 0,5 mg/0,4 mg - tamsulosin and dutasteride
dasatinib accordpharma
accord healthcare s.l.u. - dasatinibas - precursor cell lymphoblastic leukemia-lymphoma; leukemia, myelogenous, chronic, bcr-abl positive - antinavikiniai vaistai - dasatinib accordpharma is indicated for the treatment of adult patients with: newly diagnosed philadelphia chromosome positive (ph+) chronic myelogenous leukaemia (cml) in the chronic phase. chronic, accelerated or blast phase cml with resistance or intolerance to prior therapy including imatinib. ph+ acute lymphoblastic leukaemia (all) and lymphoid blast cml with resistance or intolerance to prior therapy. dasatinib accordpharma is indicated for the treatment of paediatric patients with: newly diagnosed ph+ cml in chronic phase (ph+ cml-cp) or ph+ cml-cp resistant or intolerant to prior therapy including imatinib. newly diagnosed ph+ all in combination with chemotherapy.